Loading insider details...
Beta
Latest Form 4 (Sep 3, 2026): Disposition to Issuer of 1,375 APGE shares, $185.7K.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Sep 3, 2026 | Apogee Therapeutics, Inc. (APGE) | Disposition to Issuer | 1,375 | $185.7K |
| Aug 8, 2026 | Apogee Therapeutics, Inc. (APGE) | Exercise/Conversion | 4,125 | $94.3K |
| Jul 17, 2026 | Apogee Therapeutics, Inc. (APGE) | Gift | 8,000 | n/a |
| Jul 3, 2026 | Apogee Therapeutics, Inc. (APGE) | Exercise/Conversion | 4,125 | $94.3K |
| Jun 25, 2026 | Apogee Therapeutics, Inc. (APGE) | Sale | 26,400 | $3.50M |
| Jun 12, 2026 | Oruka Therapeutics, Inc. (ORKA) | Sale | 22,417 | $1.57M |
| Jun 6, 2026 | Apogee Therapeutics, Inc. (APGE) | Exercise/Conversion | 4,125 | $94.3K |
| Jun 3, 2026 | Oruka Therapeutics, Inc. (ORKA) | Grant/Award | 9,136 | n/a |
| May 22, 2026 | Oruka Therapeutics, Inc. (ORKA) | Exercise/Conversion | 38,689 | $264.6K |
| May 9, 2026 | Apogee Therapeutics, Inc. (APGE) | Exercise/Conversion | 4,125 | $94.3K |